Jin-Qing Liu
Immunology and Microbiology · The Ohio State University
Publications
71
Citations
4,336
Est. group size
~9
Recurring co-author estimate
Active years
26
Publishing since 2000
This researcher works on liver and infectious disease topics, particularly chronic hepatitis B treatment, liver fibrosis diagnosis, and liver abscess characterization, often combining clinical data analysis with laboratory and bioinformatics methods. Their work spans clinical outcomes studies, drug comparisons (such as antiviral therapies for hepatitis B), and molecular investigations into liver-related gene markers, alongside occasional papers on unrelated topics like COVID-19 viral load and acupuncture. The listed OpenAlex immunology topics have zero relevance scores, suggesting these may not be strong descriptors of the actual body of work.
Publication output has fluctuated over the past decade, rising sharply in 2020 and 2023 with intervening lower-output years, averaging under 5 papers per year over the last 5 years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Noninvasive diagnosis of significant liver fibrosis in patients with chronic hepatitis B using nomogram and machine learning models
Scientific Reports · 2025
- Fluorofenidone attenuates choline-deficient, l-amino acid-defined, high-fat diet-induced metabolic dysfunction-associated steatohepatitis in mice
Scientific Reports · 2025
- Tenofovir amibufenamide in chronic hepatitis B: Lipid changes and 144-week safety with tenofovir disoproxil fumarate-to-tenofovir amibufenamide switch
World Journal of Gastroenterology · 2025
- Clinical Characteristics, Radiological, and Outcomes of Mucormycosis: A 14‐Year Retrospective Study From Southern China
Mycoses · 2025
- Tenofovir amibufenamide <i>vs</i> tenofovir alafenamide for treating chronic hepatitis B: A real-world study
World Journal of Gastroenterology · 2023
- Tenofovir alafenamide versus entecavir for treating hepatitis B virus-related acute-on-chronic liver failure: real-world study
Frontiers in Microbiology · 2023
- Demographics and Clinical Outcomes of Culture-Positive versus Culture-Negative Pyogenic Liver Abscess in an Asian Population
Infection and Drug Resistance · 2023
- Characteristics of Klebsiella pneumoniae pyogenic liver abscess from 2010–2021 in a tertiary teaching hospital of South China
Journal of Global Antimicrobial Resistance · 2023
- ANXA1 is identified as a key gene associated with high risk and T cell infiltration in primary sclerosing cholangitis
Human Genomics · 2023
- Role and mechanism of MiR-542-3p in regulating TLR4 in nonylphenol-induced neuronal cell pyroptosis
Phytomedicine · 2023
- Identification of AKR1B10 as a key gene in primary biliary cholangitis by integrated bioinformatics analysis and experimental validation
Frontiers in Molecular Biosciences · 2023
- Clinicopathologic characteristics of liver inflammation and fibrosis in 310 patients with chronic hepatitis B.
PubMed · 2023
- Novel CRISPR/Cas9-mediated knockout of LIG4 increases efficiency of site-specific integration in Chinese hamster ovary cell line
Biotechnology Letters · 2022
- Comparison of tenofovir alafenamide and entecavir for hepatitis B virus<b>-</b>related acute<b>-</b>on<b>-</b>chronic liver failure.
PubMed · 2022
- Viral Load Kinetics of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospitalized Individuals With Coronavirus Disease 2019
Open Forum Infectious Diseases · 2021
- PubMed×5
- The Journal of Immunology×4
- Cell×2
- Frontiers in Cell and Developmental Biology×2
- Frontiers in Immunology×2
- Wei Luo
Immunology and Microbiology · Indiana University
- Diana M. Lopez
Immunology and Microbiology · The Ohio State University
- Soo Ngoi
Immunology and Microbiology · The Ohio State University
- Prasida Holla
Immunology and Microbiology · Indiana University
- Louise Carlson
Immunology and Microbiology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile